Clinical Trial Update: Cell Therapy in HFpEF [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of a cell therapy for heart failure with preserved ejection fraction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction

Snippet

Sponsor: University Medical Centre Ljubljana | Conditions: Heart Failure With Normal Ejection Fraction | Phase 2 | Status: COMPLETED